Several policies on medicine in 217

The column of licensed pharmacists has compiled "Several Policies on Medicine in 217", so please get ready.

On January 24th, the approval of online pharmacies was fully liberalized, and the spring of medical e-commerce really came!

On January 21st, in the "Catalogue of the Third Batch of Cancellations of 39 Administrative Licensing Items Implemented by Central Designated Places" published by the State Council, the examination and approval of Internet drug trading qualification certificates B and C were cancelled, which was an unexpected gain on the eve of the Spring Festival in 217.

after the news came out, the circle of friends of practitioners in the pharmaceutical industry has been constantly screened by this news for several days. The group with the loudest cheering voice is the practitioners of pharmaceutical e-commerce. It is generally believed that the policy is to take care of the business model of pharmaceutical e-commerce, change the approval to record, simplify administration and decentralize power, and benefit retail chain enterprises. However, some people in the industry hold a calm attitude, thinking that this is only a reflection of the national policy of simplifying administration and decentralizing power, and it is not worth being overly optimistic until the corresponding supporting rules are promulgated.

On January 25th, the major reform policy of the whole chain in the pharmaceutical field will be released soon.

On January 25th, the State Council Information Office held a briefing. Wang Hesheng, director of the State Council Medical Reform Office and deputy director of the National Health and Family Planning Commission, and Wu Xun, deputy director of the Food and Drug Administration, introduced the "Several Opinions" and answered reporters' questions. In addition, responsible comrades of the Ministry of Industry and Information Technology, the Ministry of Human Resources and Social Security, the Ministry of Commerce and the relevant departments of the Bureau of Traditional Chinese Medicine also attended the meeting and answered relevant questions.

According to reports, "Several Opinions" pointed out that the key in the production process is to improve the quality and efficacy of drugs. First, strict drug listing review and approval, optimize the review and approval procedures, and promote information disclosure. The second is to accelerate the consistency evaluation of the quality and efficacy of listed generic drugs, and give policy support to drugs that pass the consistency evaluation. The third is to promote the pilot system of listing license holders in an orderly manner and encourage the research and development of new drugs. Fourth, strengthen the supervision of drug production quality and safety, and severely crack down on illegal and criminal acts of manufacturing and selling counterfeit and inferior drugs. Fifth, intensify the structural adjustment of the pharmaceutical industry and promote the withdrawal of backward enterprises. Sixth, improve the monitoring, early warning and grading response mechanism for drugs in short supply and low-priced drugs to ensure the effective supply of drugs.

Several Opinions require that the circulation order should be rectified and the circulation system should be reformed and improved. First, promote the transformation and upgrading of drug circulation enterprises and improve the urban and rural drug circulation network. The second is to implement the "two-vote system" for drug purchase and sale, and strive to push it across the country by 218. The third is to implement the classified procurement policy of drugs and reduce the false high price of drugs. Fourth, strengthen the management of drug purchase and sale contracts, and bear corresponding penalties for violating the contract. The fifth is to rectify outstanding problems in the field of drug circulation, severely punish illegal enterprises, medical institutions and related responsible personnel according to law, and record them in bad credit records. Sixth, establish a traceability mechanism of drug price information to promote the transparency of price information. Seventh, give full play to the advantages and functions of "drug circulation in internet plus" to facilitate people to use drugs.

Several Opinions emphasize that the interest-driven mechanism should be reformed and adjusted in the use process, so that drugs can return to the origin of treatment. First, public hospitals should give priority to the use of national essential drugs, strengthen drug use supervision, and promote rational drug use. The second is to further break the mechanism of supplementing medicine with medicine and strictly control the unreasonable increase of medical expenses. The third is to strengthen the role of medical insurance in regulating behavior and controlling expenses, vigorously promote the reform of medical insurance payment methods, and urge medical institutions to actively regulate medical behavior. Fourth, give full play to the role of pharmacists in rational drug use.

On January 26th, 216, the market size of retail pharmacies nationwide was 337.7 billion, with a growth rate of 9.2%

Recently, the National Bureau of Statistics released China's economic data for 216: the gross domestic product (GDP) in 216 was 74.4 trillion yuan, an increase of 6.7% over 215. At the same time, as professional medical data research institutions in China, Zhongkang CMH and Zhongkang Research Institute, as always, timely and efficiently released the heavy data of China's pharmaceutical retail industry in 216, providing decision support for pharmaceutical retail industry employees with a network of 44, terminal stores and 3 million employees directly facing health needs.

On January 27th, China officially started the legislation of the Pharmacist Law

On January 27th, CCTV broadcasted the Pharmacist Law to the world, and the National People's Congress and the National Health Planning Commission were preparing for the legislation. A few days ago, relevant officials of the State Council Medical Reform Office and National Health and Family Planning Commission said. At present, the National People's Congress has included the Pharmacist Law in the legislative plan, and is conducting relevant research with relevant departments to prepare for preliminary research. It will fully listen to opinions and suggestions from all sides in accordance with relevant requirements and accelerate the legislative process of the Pharmacist Law.

On February 4th, the cause of traditional Chinese medicine is welcoming new opportunities and entering a new development period

Recently, the first national law for the revitalization of traditional Chinese medicine in China, the Law of the People's Republic of China on Traditional Chinese Medicine, was officially promulgated, and will be implemented on July 1st, 217. The promulgation of the Law on Traditional Chinese Medicine has further opened up the qualification access and management norms for the Chinese medicine industry, making the development of Chinese medicine more legal, and the Chinese medicine industry is welcoming new opportunities and entering a new development period.

The implementation of Chinese Medicine Law is interpreted as a powerful legal aid and support to promote the healthy development of Chinese medicine. Relevant information shows that this law was included in the legislative plan of the 11th the National People's Congress Standing Committee (NPCSC) in 28; In 29, the State Council's Opinions on Deepening the Reform of the Medical and Health System issued by the Central Committee of the Communist Party of China clearly requested to speed up the legislation of traditional Chinese medicine; In December 211, the former Ministry of Health submitted the draft of the Chinese Medicine Law to the State Council for review; In December 215, the State Council submitted the draft Chinese Medicine Law to the National People's Congress Standing Committee (NPCSC) for deliberation; In December 215 and August and December 216, the National People's Congress Standing Committee (NPCSC) passed the Chinese Medicine Law after three deliberations.

As we all know, Chinese medicine is known as "the key to open the treasure house of Chinese civilization". With the change of people's health concept and the continuous innovation of medical model in recent years, Chinese medicine has gradually played a more important role in domestic health and health work. However, no matter the change of concept or the increase of demand, it only helps the development of traditional Chinese medicine, and the final implementation of the Law on Traditional Chinese Medicine makes enterprises and employees engaged in the traditional Chinese medicine industry have more rules to follow and laws to follow in their production, operation and daily work.

Several Opinions on Further Reforming and Perfecting the Policy of Drug Production, Circulation and Use (hereinafter referred to as "Several Opinions") drafted by the State Council Medical Reform Office and Food and Drug Administration jointly with relevant departments have been reviewed and approved by the plenary meeting of the State Council Medical Reform Leading Group and the meeting of the Central Leading Group for Comprehensively Deepening Reform, and will be issued and implemented by the State Council General Office in the near future.

The column of Licensed Pharmacist Examination recommends: